Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

被引：0
|
作者：
Bourhis, J. [1 ]
Sun, X. [2 ]
Pointreau, Y. [3 ]
Sire, C. [4 ]
Le Tourneau, C. [5 ]
Coutte, A. [6 ]
Kaminsky-Forrett, M-C. [7 ]
Alfonsi, M. [8 ]
Boisselier, P. [9 ]
Martin, L. [10 ]
Delord, J-P. [11 ]
Clatot, F. [12 ]
Miroir, J. [13 ]
Rolland, F. [14 ]
Crompton, P. [15 ]
Brienza, S. [15 ]
Szyldergemajn, S. A. [15 ]
Even, C. [16 ]
Tao, Y. [17 ]
机构：
[1] CHU Vaudois, Radiat Oncol, Lausanne, Switzerland
[2] HNFC, Radiat Oncol, Belfort, France
[3] Ctr Jean Bernard, Radiat Oncol, Le Mans, France
[4] Hop Scorff, Ctr Hosp Bretagne Sud, Radiat Oncol, Lorient, France
[5] Inst Curie, Med Oncol, Paris, France
[6] CHU Amiens Picardie Site Nord, Oncol Radiotherapy, Amiens, France
[7] Inst Cancerol Lorraine Alexis Vautrin, Radiat Oncol, Vandoeuvre Les Nancy, France
[8] Inst Ste Catherine, Radiat Oncol, Avignon, France
[9] ICM Reg Canc Inst Montpellier, Radiat Oncol, Montpellier, France
[10] Ctr Radiotherapie Gillaume Le Conquerant, Radiat Oncol, Le Havre, France
[11] Inst Univ Canc Toulouse Oncopole, Med Oncol, Toulouse, France
[12] Ctr Henri Becquerel, Med Oncol, Rouen, France
[13] Ctr Jean Perrin, Radiat Oncol, Clermont Ferrand, France
[14] ICO Inst Cancerol Ouest Rene Gauducheau, Radiat Oncol, St Herblain, France
[15] Debiopharm Int SA, CR&D, Lausanne, Switzerland
[16] Inst Gustave Roussy, Med Oncol, Villejuif, France
[17] Inst Gustave Roussy, Radiat Oncol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA65
引用
收藏
页码：902 / 902
页数：1
相关论文
共 50 条
  • [1] Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
    Sun, Xu-Shan
    Tao, Yungan
    Le Tourneau, Christophe
    Pointreau, Yoann
    Sire, Christian
    Kaminsky, Marie-Christine
    Coutte, Alexandre
    Alfonsi, Marc
    Boisselier, Pierre
    Martin, Laurent
    Miroir, Jessica
    Ramee, Jean-Francois
    Delord, Jean-Pierre
    Clatot, Florian
    Rolland, Frederic
    Villa, Julie
    Magne, Nicolas
    Elicin, Olgun
    Gherga, Elisabeta
    Nguyen, France
    Lafond, Cedrick
    Bera, Guillaume
    Calugaru, Valentin
    Geoffrois, Lionnel
    Chauffert, Bruno
    Zubel, Angela
    Zanna, Claudio
    Brienza, Silvano
    Crompton, Philippa
    Rouits, Elisabeth
    Gollmer, Kathrin
    Szyldergemajn, Sergio
    Bourhis, Jean
    LANCET ONCOLOGY, 2020, 21 (09): : 1173 - 1187
  • [2] 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck
    Bourhis, J.
    Sun, X.
    Le Tourneau, C.
    Pointreau, Y.
    Sire, C.
    Kaminsky-Forrett, M-C.
    Coutte, A.
    Alfonsi, M.
    Boisselier, P.
    Martin, L.
    Delord, J-P.
    Clatot, F.
    Biau, J.
    Rolland, F.
    Gollmer, K.
    Szyldergemajn, S. A.
    Even, C.
    Tao, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1168 - S1168
  • [3] Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck
    Planting, AST
    deMulder, PHM
    deGraeff, A
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 61 - 65
  • [4] A phase II trial of postoperative radiotherapy (RT), cisplatin, and panitumumab in patients with high-risk, resected locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Ferris, R. L.
    Kotsakis, A. P.
    Heron, D. E.
    Kim, S.
    Duvvuri, U.
    Kubicek, G. J.
    Grandis, J. R.
    Johnson, J. T.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A phase I/II randomized study of Debio1143 combined with concurrent cheitioradialion therapy (CCRT) nt palienis with locally advanced squaMOUS celi carcinoma of the head and neck (LA-SCCHN).
    Le Tourneau, Christophe
    Tao, Yungan
    Delord, Jean-Pierre
    Brienza, Silvan
    Vuagniaux, Gregoire
    Sablin, Marle-Paula
    Zanna, Claudio
    Bourhis, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Randomized phase II trial of cisplatin and radiotherapy with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Martins, Renato
    Parvathaneni, Upendra
    Sharma, Anand K.
    Raez, Luis E.
    Papagikos, Michael A.
    Yunus, Furhan
    Bauman, Julie E.
    Eaton, Keith D.
    Liao, Jay Justin
    Mendez, Eduardo
    Futran, Neal
    Kurland, Brenda F.
    Wang, David X.
    Xiaoyu, Shawn
    Wallace, Sarah G.
    Hayes, David N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study
    Gregoire, Vincent
    Hamoir, Marc
    Chen, Changhu
    Kane, Madeleine
    Kawecki, Andrzej
    Julka, Pramod K.
    Wang, Hung-Ming
    Prasad, Srihari
    D'Cruz, Anil K.
    Radosevic-Jelic, Ljiljana
    Kumar, Rejnish R.
    Korzeniowski, Stanislaw
    Fijuth, Jacek
    Machiels, Jean-Pascal
    Sellers, Mark V.
    Tchakov, Ilian
    Raben, David
    RADIOTHERAPY AND ONCOLOGY, 2011, 100 (01) : 62 - 69
  • [8] High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase II study
    Regine, WF
    Valentino, J
    John, W
    Storey, G
    Sloan, D
    Kenady, D
    Patel, P
    Pulmano, C
    Arnold, SM
    Mohiuddin, M
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (06): : 543 - 549
  • [9] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [10] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
12345